Sartorius is a leading international partner of biopharma research and manufacturing. We help our customers simplify progress from drug discovery to manufacturing so that more people can have access to better medicine. And simplifying progress starts with our employees who move things forward by realizing ambitious ideas and growing alongside with the company. Our product portfolio covers two customer groups: With innovative laboratory instruments and consumables, Sartorius focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. Our broad bioprocess product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. Based in Göttingen, Germany, Sartorius also has a strong global reach with more than 60 production and sales sites worldwide. We regularly expand our portfolio through the acquisition of complementary technologies. In 2025, Sartorius generated sales revenue of around 3.5 billion euros. Currently, more than 14,000 employees from 110+ nations are working for customers around the globe. Join our team, partner or collaborate with us.
解锁市场时间线与信号动态
最近 90 天内有 374 个信号。
该公司进入各个市场的顺序 — 从最早到最新
IT Inhouse Consultant ServiceNow (x|f|m)
Careers at Sartorius
注册以查看完整信号动态
Sartorius 的国际扩张与竞争对手的对比情况
条形图显示所对比公司之间的相对规模。
5 项指标| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
Sartorius你 | 25 | 0 | +159% | 219 | 37 |
快速扩张——最近 90 天新增 288 个职位,较上一周期增长 127%。 以 Engineering 为主,集中在 德国。
Madrid, Community of Madrid, Spain · 今天
IT Inhouse Consultant ServiceNow (x|f|m)
Marlborough, MA · 前天
Lipid Nanoparticle & mRNA Synthesis Intern - Marlborough, MA
Belgium · 3天前
Technical Sales Specialist Advanced Therapy Solutions (F/M)
在技术栈中检测到 60 项技术。
覆盖 179 个市场 的 13 个进行中的广告系列。
最近 90 天获 7 次提及。
Sartorius Picus NxT 电子移液器提供 0.2-10,000 µl 精确液体处理,轻量化设计、电子控制、多通道选项及 ISO 认证校准,适用于研究和生物制药应用。
德国DAX指数下跌0.34%至26,002点,受债券收益率和油价上涨影响。Tonies股价尽管收入增长仍下跌4.6%,Sartorius因瑞银升级上涨5.1%。
瑞银分析师Matthew Weston将Sartorius从中性升级至买入,目标价升至300欧元。预期生物工艺解决方案因耗材需求及美国生产迁移而强劲增长。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Sartorius 的业务、市场和增长信号的快速解答。